Abstract:BACKGROUND: Major depressive disorder (MDD) is associated with abnormal neural activities and brain connectivity. EEG microstate is a voltage topology map that reflects transient activations of the brain network. A limited number of studies on EEG microstate in MDD have focused on differences between patients and healthy controls. However, EEG microstate changes in MDD patients before and after drug treatment have not been evaluated. We assessed EEG microstate characteristics and evaluated changes in brain network dynamics in MDD patients before and after drug treatment. Moreover, we evaluated the neuro-electrophysiological mechanisms of antidepressant therapies.METHODS: 64-channel resting EEG was obtained from 101 patients with first-episode untreated depression (0 week) and 45 healthy controls (HC) from January to December 2020. MDD patients were treated with selective serotonin reuptake inhibitors (SSRI). EEG data for 51 MDD patients who had completed an 8-week follow-up was collected. After pre-processing, EEG data from different groups were subjected to microstate analysis, and the atomize and agglomerate hierarchical clustering (AAHC) was into 4 microstates. Next, EEG signals from each patient were fitted using templates of 4 microstates. Finally, microstate indices were collected and analyzed.RESULTS: Global clustering generated 4 microstates (A, B, C, D) in all subjects, which explained 65-84% of the global variance. Compared to HC, the duration of microstate D reduced while those of microstates A and B increased in MDD patients. After the 8-week treatment period, the duration and coverage of microstate D increased, the frequency of microstate A and transition probability of microstate D to A reduced, while transition probability of microstate B to D and D to B increased in MDD patients. There were no differences in microstate features between HC and MDD at 8 weeks. In patients with first-episode untreated depression, lower average durations of microstate D, relatively higher frequencies of microstate C and lower transition probabilities of microstate D to B correlated with better effects after 8 weeks. The higher occurrence and proportion of microstate C at 8 weeks was positively correlated with the HAMD score and reduction rate. The same observation was reached for the transition probability of microstate A to C. However, the transition probability of microstate D to B showed a negative correlation with the HAMD score at 8 weeks.CONCLUSION: Microstate D is a potential electrophysiological trait of MDD and can predict treatment outcomes of SSRIs. Therefore, EEG microstate analysis may not only be an objective method for evaluating treatment outcomes of depression, but is also a potential new approach for exploring the neuro-electrophysiological mechanisms of antidepressant therapy. Public title: Multidimensional diagnosis, individualized treatment and management techniques based on clinic-pathological characteristics of depressive disorder; Registration number: ChiCTR1900026600; Date of registration: 2019-10-15; URL: http://www.chictr.org.cn/index.aspx.

Electroencephalographic Network Topologies Predict Antidepressant Responses in Patients With Major Depressive Disorder

Sub-hubs of Baseline Functional Brain Networks Are Related to Early Improvement Following Two-Week Pharmacological Therapy for Major Depressive Disorder.

An Electroencephalographic Signature Predicts Antidepressant Response in Major Depression

Predict Value of Functional Topological Features for Early Response to Antidepressant Treatment in Major Depressive Disorder

Local and large-scale resting-state oscillatory dysfunctions for early antidepressant response prediction in major depressive disorder

Global Topology Alteration of the Brain Functional Network Affects the 8-Week Antidepressant Response in Major Depressive Disorder

In perspective of specific symptoms of major depressive disorder: Functional connectivity analysis of electroencephalography and potential biomarkers of treatment response

Prediction of Clinical Outcomes With EEG Microstate in Patients With Major Depressive Disorder

Disrupted Topology of Hippocampal Connectivity is Associated with Short-Term Antidepressant Response in Major Depressive Disorder.

Enhanced default mode network functional connectivity links with electroconvulsive therapy response in major depressive disorder

Distinct MRI-based functional and structural connectivity for antidepressant response prediction in major depressive disorder

Individual deviations from normative electroencephalographic connectivity predict antidepressant response

EEG microstates as markers of major depressive disorder and predictors of response to SSRIs therapy

Electroconvulsive Therapy-Induced Changes in Functional Brain Network of Major Depressive Disorder Patients: A Longitudinal Resting-State Electroencephalography Study

Divergent Topological Architecture of the Default Mode Network As a Pretreatment Predictor of Early Antidepressant Response in Major Depressive Disorder

Optimizing Antidepressant Efficacy: Generalizable Multimodal Neuroimaging Biomarkers for Prediction of Treatment Response

Association Between Antidepressant Efficacy and Interactions of Three Core Depression-Related Brain Networks in Major Depressive Disorder

Predicting Escitalopram Monotherapy Response in Depression: the Role of Anterior Cingulate Cortex

The effects of antidepressant treatment on resting-state functional brain networks in patients with major depressive disorder.

Predicting Responses to Electroconvulsive Therapy in Adolescents with Treatment-Refractory Depression Based on Resting-State fMRI

Electrophysiological predictors of early response to antidepressants in major depressive disorder